Cargando…
No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034948/ https://www.ncbi.nlm.nih.gov/pubmed/36708089 http://dx.doi.org/10.1111/jdi.13983 |
| _version_ | 1784911319880695808 |
|---|---|
| author | Hirano, Tsutomu |
| author_facet | Hirano, Tsutomu |
| author_sort | Hirano, Tsutomu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10034948 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100349482023-03-24 No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial Hirano, Tsutomu J Diabetes Investig Letter to the Editor John Wiley and Sons Inc. 2023-01-27 /pmc/articles/PMC10034948/ /pubmed/36708089 http://dx.doi.org/10.1111/jdi.13983 Text en © 2023 The Author. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letter to the Editor Hirano, Tsutomu No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial |
| title | No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial |
| title_full | No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial |
| title_fullStr | No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial |
| title_full_unstemmed | No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial |
| title_short | No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial |
| title_sort | no change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the prominent trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034948/ https://www.ncbi.nlm.nih.gov/pubmed/36708089 http://dx.doi.org/10.1111/jdi.13983 |
| work_keys_str_mv | AT hiranotsutomu nochangeinsmalllowdensitylipoproteincholesterollevelswithpemafibratemightexplainthenegativeresultsoftheprominenttrial |